From respiratory disease to disability, the third dose to excessive fragility – Health

From respiratory diseases to nervous system diseases to various forms of disability. These are people with anaphylaxis for whom a third booster dose of the Covid vaccine will be provided. This is foreseen in the new circular “Update of indications for the administration of additional doses and ‘booster’ doses as part of the vaccination campaign against SARS-CoV-2/COVID-19” issued by the Ministry of Health.

For purposes of a booster-dose administration plan, the circular states that “it will be possible to progressively administer an additional dose of Cominarty Vaccine (authorized by the EMA for this indication) to severely impaired persons, regardless of age, and to all persons over 60 years of age. a year or more, provided that at least six months have passed since the end of the initial vaccination course.”

Concomitant/pre-existing conditions of high fragility, with reference to the booster dose of the SARS-CoV-2/COVID-19 vaccine, are: respiratory diseases (idiopathic pulmonary fibrosis; respiratory diseases requiring oxygen therapy); Cardiovascular disease (heart failure in advanced degree; post-traumatic heart patients); Neurological diseases (amyotrophic lateral sclerosis and other motor neuron diseases, multiple sclerosis, muscular dystrophy, infantile cerebral palsy, myasthenia gravis, disorders of the immune nervous system). And again: diabetes and other severe endocrine disorders (type 1 diabetes; type 2 diabetes treated with at least two diabetes medications or with complications; Addison’s disease; hypopituitarism); Liver disease (cirrhosis). Cerebral vascular disease (cerebral ischemic-hemorrhagic event with impaired neurological and cognitive autonomy; stroke in 2020-21; stroke before 2020 in the order of ≥ 3); hemoglobinopathy (thalassemia major, sickle cell anemia, other severe anemias); Other causes (cystic fibrosis, Down syndrome, severe obesity). Physical, sensory, mental and mental disability (serious disability under Law 104/1992, art. 3, paragraph 3).

Reproduction is reserved © Copyright ANSA

Back to top button